Paclitaxel and radiotherapy: Sequence-dependent efficacy a preclinical model

Clinical Cancer Research

Volumn 5, Issue 8, 1999, Pages 2213-2222

  Niero, Alessandra ^a   Emiliani, Ermanno ^a   Monti, Giuseppe ^a   Pironi, Flavio ^a   Turci, Livia ^a   Valenti, Anna Maria ^a   Marangolo, Maurizio ^a  

^a SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CELL STRAIN HT29; COLON ADENOCARCINOMA; DOSE CALCULATION; DOSE RESPONSE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT PLANNING;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CELL SURVIVAL; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOSE-RESPONSE RELATIONSHIP, RADIATION; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HT29 CELLS; HUMANS; PACLITAXEL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION-SENSITIZING AGENTS; TIME FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032803234     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Liebmann, J. E., Cook, J. A., Lipschultz, C., Teague, D., Fisher, J., and Mitchell, J. B. Cytotoxic studies of paclitaxel (Taxol) in human tumor cell lines. Br. J. Cancer, 68: 1104-1109, 1993.
2. Rowinsky, E. K., Cazenave, C. A., and Donehower, R. C. Taxol: a novel investigational antimicrotubule agent. J. Natl. Cancer Inst., 82: 1247-1259, 1990.
3. Schiff, P. B., Fant, J., and Horwitz, S. B. Promotion of microtubule assembly in vitro by Taxol. Nature (Lond.), 277: 665-667, 1979.
4. Schiff, P. B., and Horwitz, S. B. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA, 77: 1561-1565, 1980.
5. Tishler, R. B., Schiff, P. B., Geard, C. R., and Hall, E. J. Taxol: a novel radiation sensitizer. Int. J. Radiat. Oncol. Biol. Phys., 22: 613-617, 1992.
6. Liebmann, J., Cook, J. A., Fisher, J., Teague, D., and Mitchell, J. B. Changes in radiation survival curve parameters in human tumor and rodent cells exposed to paclitaxel (Taxol). Int. J. Radiat. Oncol. Biol. Phys., 29: 559-564, 1994.
7. Hei, T. K., and Hall, E. J. Taxol, radiation, and oncogenic transformation. Cancer Res., 53: 1368-1372, 1993.
8. Liebmann, J., Cook, J. A., Fisher, J., Teague, D., and Mitchell, J. B. In vitro studies of Taxol as a radiation sensitizer in human tumor cells. J. Natl. Cancer Inst., 86: 441-446, 1994.
9. Steren, A., Sevin, B. U., Perras, J., Ramos, R., Angioli, R., Nguyen, H. N., Koechli, O. R., and Averette, H. E. Taxol as a radiation sensitizer: a flow cytometric study. Gynecol. Oncol., 50: 89-93, 1993.
10. Rodriguez, M., Sevin, B. U., Perras, J., Nguyen, H. N., Pham, C., Steren, A. J., Koechli, O. R., and Averette, H. E. Paclitaxel: a radiation sensitizer of human cervical cancer cells. Gynecol. Oncol., 57: 165-169, 1995.
11. Milas, L., Hunter, N. R., Mason, K. A., Milross, C. G., and Peters, L. J. Tumor reoxygenation as a mechanism of taxol-induced enhancement of tumor radioresponse. Acta Oncol., 34: 409-412, 1995.
12. Milas, L., Hunter, N. R., Mason, K. A., Milross, C. G., Saito, Y., and Peters, L. J. Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel. Cancer Res., 55: 3564-3568, 1995.
13. Zupi, G., Marangolo, M., Arancia, G., Greco, C., Laudonio, N., Iosi, F., Formisano, G., and Malorni, W. Modulation of the cytotoxic effect of 5-fluorouracil by N-methylformamide on a human colon carcinoma cell lines. Cancer Res., 48: 6193-6200, 1988.
14. Fertil, B., Dertinger, H., Courdi, A., and Malaise, E. P. Mean inactivation dose: a useful concept for intercomparison of human cell survival curves. Radiat. Res., 99: 73-84, 1984.
15. Zamai, L., Falcieri, E., Marhefka, G., and Vitale, M. Supravital exposure to propidium iodide identifies apoptotic cells in the absence of nucleosomal DNA fragmentation. Cytometry, 23: 303-311, 1996.
16. 2/M delay and cellular radiosensitivity. Int. J. Radiat. Biol., 66: 313-319, 1994.
17. Kerr, J. F. R., Winterford, C. M., and Harmon, B. V. Apoptosis. Its significance in cancer and cancer therapy. Cancer (Phila.), 73: 2013-2026, 1994.
18. Gorman, A. M., Samali, A., McGowan, A. J., and Cotter, T. G. Use of flow cytometry techniques in studying mechanisms of apoptosis in leukemic cells. Cytometry, 29: 97-105, 1997.
19. Oltvai, Z., Milliman, C., and Korsmeyer, S. J. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 74: 609-619, 1993.
20. Chresta, C. M., Masters, J. R. W., and Hickman, J. A. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res., 56: 1834-1841, 1996.
21. Hennequin, C., Giocanti, N., and Favaudon, V. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells. Cancer Res., 56: 1842-1850, 1996.
22. Chi, K. H., Chow, K. C., and Chen, K. Y. Optimal combination of Taxol with radiotherapy. Proc. Am. Assoc. Cancer Res., 36: 612, 1995.
23. Choy, H., Rodriguez, F. F., Koester, S., Hilsenbeck, S., and Von Hoff, D. D. Investigation of Taxol as a potential radiation sensitizer. Cancer (Phila.), 71: 3774-3778, 1993.
24. Van Rijn, J., Van der Berg, J., and Meijer, O. W. M. Proliferation and clonal survival of human lung cancer cells treated with fractionated irradiation in combination with paclitaxel. Int. J. Radiat. Oncol. Biol. Phys., 33: 635-639, 1995.
25. Lokeshwar, B. L., Ferrell, S. M., and Block, N. L. Enhancement of radiation response of prostatic carcinoma by Taxol: therapeutic potential for late-stage malignancy. Anticancer Res., 15: 93-98, 1995.
26. Leonard, C. E., Chan, D. C., Chou, T. C., Kumar, R., and Bunn, P. A. Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck. Cancer Res., 56: 5198-5204, 1996.
27. Gupta, N., Hu, L., Fan, P. D., and Deen, D. F. Effect of Taxol and radiation on brain tumor cell lines. Proc. Am. Assoc. Cancer Res., 35: 647, 1994.
28. Stromberg, J. S., Lee, Y. I., Armour, E. P., Martinez, A. A., and Corry, P. M. Lack of radiosensitization after paclitaxel treatment of three human carcinoma cell lines. Cancer (Phila.), 75: 2262-2268, 1995.
29. Minarik, L., and Hall, E. J. Taxol in combination with acute and low dose rate irradiation. Radiother. Oncol., 32: 124-128, 1994.
30. Erlich, E., McCall, A. R., Potkul, R. K., Walter, S., and Vaughan, A. Paclitaxel is only a weak radiosensitizer of human cervical carcinoma cell lines. Gynecol. Oncol., 60: 251-254, 1996.
31. Jonh, M., Flam, M., Legha, S., and Phillips, T. (eds.). Chemoradiation: An Integrated Approach to Cancer Treatment, Ed. 1. Philadelphia, J. B. Lippincott Co., 1995.
32. McGinn, C. J., Shenwach D. S., and Lawrence, T. S. Radiosensitizing nucleotides. J. Natl. Cancer Inst., 88: 1193-1203, 1996.
33. Ward, J. F. Mechanism of DNA repair and their potential modification for radiotherapy. J. Radiat. Oncol. Biol. Phys., 12: 1027-1032, 1986.
34. Giocanti, N., Hennequin, C., Balosso, I., Mahler, M., and Favaudon, V. DNA repair and cell cycle interaction in radiation sensitization by the topoisomerase II poison etoposide. Cancer Res., 53: 2105-2111, 1993.
35. Safran, H., King, T., Choy, H., Gollerkeri, A., Kwakwa, H., Lopez, F., Cole, B., Myes, J., Tarpey, J., and Rosmarin, A. p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma. Cancer (Phila.), 78: 1203-1210, 1996.
36. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78: 539-542, 1994.
37. Miyashita, T., and Reed, J. C. Tumor suppressor p53 is a direct transcriptional activator of human bax gene. Cell, 80: 293-299, 1995.